The news: Four major medical societies introduced a new framework for assessing women’s cardiovascular risk across four life stages, from puberty through postmenopause. The stages are defined by hormonal and reproductive changes, with pregnancy considered a separate window for assessment. The joint guidance comes from the American Heart Association (AHA), American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine. It aims to help pediatricians, OB/GYNs, and primary care providers recognize cardiovascular risks and coordinate preventive care across specialties.

Zooming out: The framework highlights cardiovascular risk factors tied to women’s life stages and health conditions:

• Menstrual health: Heavy or irregular periods can signal underlying conditions such as polyendocrine metabolic ovarian syndrome (PMOS) associated with cardiovascular risk.
• Mental health: Anxiety, depression, and eating disorders, which are more common among women, can contribute to poor cardiovascular health.
• Perimenopause: Changes in cholesterol and metabolic health during this transition can signal cardiovascular risk.

Why it matters: Routine women’s healthcare offers opportunities to identify cardiovascular risk, and the new framework aims to help clinicians to spot it earlier and connect women with ongoing preventive care.

Pregnancy shows what’s at stake. High blood pressure complications during pregnancy are associated with a higher chance of cardiovascular disease later in life. Yet only 60% of US women with these complications receive follow-up care for their high blood pressure within six months of delivery, per the organizations.

And the payoff for catching cardiovascular risks early is clear after menopause. Although most heart attacks, strokes, and heart failure events occur during this stage, early intervention can prevent more than 80% of them, per the organizations.

Implications for healthcare and pharma marketers: Cardiovascular disease kills more US women annually than breast cancer, lung cancer, and chronic lung disease combined, yet just 41% of women recognize cardiovascular disease as their greatest health threat, per the AHA. That gap leaves room to improve awareness, particularly through education tied to women's reproductive and hormonal health.

Marketers can equip OB/GYNs and primary care providers with educational materials to share during routine visits, helping patients understand how menstrual health, pregnancy complications, and menopause-related changes relate to cardiovascular risk. Health systems can address the postpartum follow-up gap with practical prevention tips, blood pressure monitoring guidance, and appointment reminders that support continued care.

This content is part of EMARKETER’s subscription Briefings, where we pair daily updates with data and analysis from forecasts and research reports. Our Briefings prepare you to start your day informed, to provide critical insights in an important meeting, and to understand the context of what’s happening in your industry. Not a subscriber? Click here to get a demo of our full platform and coverage.